![]() |
![]() |
Legal status
Patent not validated
(51) | INT.CL. | A61K 38/48 | |
A61P 29/00 |
(11) | Number of the document | 2104510 |
(13) | Kind of document | T |
(96) | European patent application number | 07872380.6 |
Date of filing the European patent application | 2007-12-17 | |
(97) | Date of publication of the European application | 2009-09-30 |
(45) | Date of publication and mention of the grant of the patent | 2011-09-21 |
(46) | Date of publication of the claims translation |
(86) | Number | PCT/FR2007/002091 |
Date | 2007-12-17 |
(87) | Number | WO 2008/090287 |
Date | 2008-07-31 |
(30) | Number | Date | Country code |
0611244 | 2006-12-22 | FR |
(72) |
Favre, Christine, FR
Auguet, Michel, FR
Chabrier De Lassauniere, Pierre-Etienne, FR
|
(73) |
IPSEN PHARMA S.A.S.,
65, Quai Georges Gorse, 92100 Boulogne-Billancourt,
FR
|
(54) | UTILISATION D`AU MOINS UNE NEUROTOXINE BOTULIQUE POUR TRAITER LA DOULEUR INDUITE PAR LES TRAITEMENTS THERAPEUTIQUES DU VIRUS DU SIDA |
USE OF AT LEAST ONE BOTULISM NEUROTOXIN FOR TREATING THE PAIN INDUCED BY THERAPEUTIC TREATMENTS FOR THE AIDS VIRUS |